Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA: 603392)
China
· Delayed Price · Currency is CNY 68.09
-0.37 (-0.54%)
Jan 27, 2025, 3:00 PM CST
SHA:603392 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 24, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 86,041 | 95,280 | 114,799 | 134,459 | 87,383 | - | Upgrade
|
| Market Cap Growth | 70.22% | -17.00% | -14.62% | 53.87% | - | - | Upgrade
|
| Enterprise Value | 81,005 | 90,027 | 108,497 | 134,052 | 86,784 | - | Upgrade
|
| Last Close Price | 68.01 | 74.78 | 89.12 | 107.37 | 69.72 | - | Upgrade
|
| PE Ratio | - | 76.37 | 24.24 | 66.52 | 129.07 | - | Upgrade
|
| Forward PE | 46.00 | 17.29 | 20.47 | 76.21 | 97.59 | - | Upgrade
|
| PS Ratio | 34.53 | 17.29 | 10.26 | 23.38 | 37.12 | - | Upgrade
|
| PB Ratio | 7.27 | 7.40 | 9.14 | 29.47 | 33.86 | - | Upgrade
|
| P/TBV Ratio | 8.70 | 7.81 | 9.53 | 32.20 | 37.55 | - | Upgrade
|
| P/FCF Ratio | - | 251.96 | 35.84 | 212.03 | 1123.62 | - | Upgrade
|
| P/OCF Ratio | 122.64 | 61.96 | 27.78 | 79.94 | 186.63 | - | Upgrade
|
| EV/Sales Ratio | 32.53 | 16.34 | 9.70 | 23.31 | 36.86 | - | Upgrade
|
| EV/EBITDA Ratio | - | 57.27 | 20.09 | 57.44 | 107.25 | - | Upgrade
|
| EV/EBIT Ratio | - | 66.00 | 20.61 | 59.91 | 119.74 | - | Upgrade
|
| EV/FCF Ratio | -529.92 | 238.07 | 33.88 | 211.39 | 1115.90 | - | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.06 | 0.03 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | - | 0.19 | 0.05 | 0.12 | 0.10 | 0.09 | Upgrade
|
| Debt / FCF Ratio | - | 0.82 | 0.09 | 0.45 | 1.00 | 0.19 | Upgrade
|
| Asset Turnover | 0.16 | 0.35 | 0.96 | 1.09 | 0.83 | 0.59 | Upgrade
|
| Inventory Turnover | 0.98 | 1.13 | 1.64 | 1.71 | 1.49 | 1.54 | Upgrade
|
| Quick Ratio | 4.10 | 3.49 | 3.20 | 1.67 | 1.86 | 1.24 | Upgrade
|
| Current Ratio | 4.61 | 3.86 | 3.49 | 1.96 | 2.39 | 1.80 | Upgrade
|
| Return on Equity (ROE) | -2.26% | 9.80% | 56.79% | 58.22% | 32.77% | 14.25% | Upgrade
|
| Return on Assets (ROA) | -1.54% | 5.34% | 28.27% | 26.51% | 15.98% | 4.69% | Upgrade
|
| Return on Capital (ROIC) | -1.80% | 6.55% | 37.20% | 37.26% | 21.27% | 6.24% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 10.46% | 41.31% | 47.81% | 27.10% | 8.93% | Upgrade
|
| Earnings Yield | -0.34% | 1.31% | 4.13% | 1.50% | 0.77% | - | Upgrade
|
| FCF Yield | -0.18% | 0.40% | 2.79% | 0.47% | 0.09% | - | Upgrade
|
| Dividend Yield | 0.47% | 0.43% | 0.80% | 0.09% | 0.13% | - | Upgrade
|
| Payout Ratio | 0.00% | 72.73% | 2.69% | 5.58% | 0.24% | 0.50% | Upgrade
|
| Buyback Yield / Dilution | 0.06% | -0.86% | -1.55% | -2.96% | -8.71% | -2.96% | Upgrade
|
| Total Shareholder Return | 0.53% | -0.43% | -0.75% | -2.87% | -8.59% | -2.96% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.